Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
IJID Regions|August 18, 2025
Tuberculosis as a significant cause of uveitis-related blindness: current referral trends at a tertiary uveitis center in IndonesiaIkhwanuliman Putera, Ulifna Alfiya Sifyana, Saskia M Rombach, et al.
Frontiers in Immunology|March 10, 2022
Pediatric Prediction Model for Low Immunoglobulin G Level Based on Serum Globulin and Illness StatusNarissara Suratannon, Phimphika Tantithummawong, Cameron Paul Hurst, et al.
Acta Ophthalmologica|February 9, 2019
The treatment outcomes in IgG4-related orbital disease: a systematic review of the literatureSanne E Detiger, A Faiz Karim, Robert M Verdijk, et al.
Ophthalmology and Therapy|February 24, 2025
Artificial Intelligence-Based Uveitis Diagnosis Through Retinal Vasculature Analysis: A Paradigm Shift in Ocular TuberculosisIkhwanuliman Putera, Jose D Vargas Quiros, Saskia M Rombach, et al.
Journal of Neuroimmunology|September 13, 2002
Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigensGeorges M G M Verjans, P Martin van Hagen, Alexander van der Kooi, et al.
Clinical Immunology (Orlando, Fla.)|January 29, 2019
Precursor B-cell development in bone marrow of Good syndrome patientsLucía Del Pino Molina, Marjolein Wentink, Marcel van Deuren, et al.
Journal of Clinical Immunology|February 1, 2023
The Association of Serum Immunoglobulins with Risk of Cardiovascular Disease and Mortality: the Rotterdam StudySamer R Khan, Virgil A S H Dalm, M Kamran Ikram, et al.
Frontiers in Immunology|April 26, 2021
Determinants of Serum Immunoglobulin Levels: A Systematic Review and Meta-AnalysisSamer R Khan, Anna C van der Burgh, Robin P Peeters, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapyBert Bernard, Astrid Capello, Martin van Hagen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 31, 2014
The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activationSita Virakul, Virgil A S H Dalm, Dion Paridaens, et al.
Pageof 18